{{Rsnum
|rsid=9494266
|Gene=C6orf217
|Chromosome=6
|position=135530435
|Orientation=plus
|GMAF=0.2355
|Gene_s=LINC00271
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.9 | 13.3 | 85.8
| HCB | 0.7 | 15.3 | 83.9
| JPT | 0.0 | 12.4 | 87.6
| YRI | 66.0 | 29.3 | 4.8
| ASW | 49.1 | 33.3 | 17.5
| CHB | 0.7 | 15.3 | 83.9
| CHD | 0.9 | 15.6 | 83.5
| GIH | 0.0 | 22.8 | 77.2
| LWK | 50.0 | 42.7 | 7.3
| MEX | 0.0 | 24.1 | 75.9
| MKK | 43.6 | 46.8 | 9.6
| TSI | 1.0 | 7.8 | 91.2
| HapMapRevision=28
}}

Originally reported to be associated with [[type-2 diabetes]] in a genome-wide association study; yet then reported not to be associated with either T2D or related metabolic traits in a large Danish population (ultimately 17,000 patients for the latter study).{{PMID|18227995}}

{{PMID Auto
|PMID=17668382
|Title=Type 2 diabetes whole-genome association study in four populations: the DiaGen consortium.
|OA=1
}}

{{PMID Auto
|PMID=19783549
|Title=Detecting natural selection by empirical comparison to random regions of the genome.
|OA=1
}}

{{PMID Auto
|PMID=21278902
|Title=Genetic risk profiling for prediction of type 2 diabetes.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}